GSK announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for its malaria candidate vaccine Mosquirix^TM, also known as RTS,S, in children aged 6 weeks to 17 months. Following this decision, the World Health Organization (WHO) will now formulate a policy recommendation on use of the vaccine in national immunisation programmes once approved by national regulatory authorities.

Researchers develop a tiny wireless device that, once implanted in the brain, can be activated by remote control to deliver targeted drugs. Size of device is of the width of a human hair. It may be used to treat pain, depression, epilepsy and other neurological disorders in people by targeting therapies to specific brain areas. The researchers believe that similar, more flexible devices could have applications in other areas of the body too, including peripheral organs. The study is published in the Cell.

Bosch, a leading global supplier of technology and services, has got the Zinnov Awards for its Eyecare device that was adjudged as an innovation with a potential to solve large scale global problems.

(Business Wire India); Apollo Children’s Hospital has once again showcased its expertise and technical know-how on implementing some of the latest technologies for the benefit of patients. Surgeries performed at the Children’s Hospital using the da Vinci robot provides patients with all the advantages like quicker discharge time, minimal scarring, smaller incisions and less blood loss that conventional laparoscopy offers over open surgeries.